TABLE 1.
Selected Characteristics of Injection Drug Using Women at Enrollment in the Gynecological Substudy of ALIVE in Baltimore, Maryland, 1992−1997
| HIV-Uninfected | HIV-Infected N = 146 | ||
|---|---|---|---|
| Characteristic | n (%) | n (%) | P* |
| Race | |||
| Black, non-Hispanic, and Hispanic | 68 (93) | 140 (96) | 0.38 |
| White, non-Hispanic | 5 (7) | 6 (4) | |
| Age (yrs) | |||
| <35 | 20 (27) | 58 (40) | 0.12 |
| 35−39 | 22 (30) | 48 (33) | |
| 40−45 | 20 (27) | 28 (19) | |
| >45 | 11 (15) | 12 (8) | |
| Cigarette smoking in last 6 mo | |||
| Yes | 61 (84) | 130 (91) | 0.11 |
| Among smokers, packs/d in last 6 mo | |||
| <1 | 26 (43) | 47 (36) | 0.39 |
| ≥1 | 35 (57) | 83 (64) | |
| Crack use in last 6 mo | |||
| Yes | 17 (23) | 38 (26) | 0.67 |
| Injection drug use in last 6 mo | |||
| Injection of heroin only | |||
| Yes | 30 (39) | 75 (46) | 0.32 |
| Injection of cocaine only | |||
| Yes | 24 (32) | 68 (42) | 0.13 |
| Injection of both heroin and cocaine | |||
| Yes | 21 (28) | 53 (33) | 0.43 |
| Marijuana use in last 6 mo | |||
| Yes | 22 (29) | 42 (26) | 0.62 |
| Alcohol in last 6 mo | |||
| Yes | 40 (55) | 85 (58) | 0.63 |
| Ever oral contraceptive use† | |||
| Yes | 45 (62) | 85 (58) | 0.84 |
| High-risk sex‡ in last 6 mo | |||
| Yes | 31 (42) | 49 (34) | 0.20 |
| No. male sex partners in last 6 mo | |||
| 0 | 16 (22) | 44 (30) | 0.19 |
| 1 | 47 (64) | 75 (51) | |
| >1 | 10 (14) | 27 (19) | |
| No. male sex partners in last 10 yrs† | |||
| 0−2 | 28 (38) | 26 (18) | 0.01 |
| 3−7 | 29 (40) | 61 (42) | |
| >7 | 14 (19) | 42 (29) | |
| No. live births in lifetime† | |||
| 0−1 | 23 (32) | 43 (29) | 0.92 |
| 2 | 17 (23) | 28 (19) | |
| >2 | 28 (38) | 46 (32) | |
| CD4 category (cells/mm3) | |||
| >500 | N/A | 63 (43) | N/A |
| 200−500 | 52 (36) | ||
| <200 | 30 (21) | ||
| HIV treatment in last 6 mo | |||
| None | N/A | 82 (56) | N/A |
| Mono-therapy | 56 (38) | ||
| Dual-therapy | 7 (5) | ||
| HAART | 1 (1) |
Percentages may not sum to 100% due to missing data.
*
χ2 test for heterogeneity between HIV serogroups.
†
Assessed at baseline enrollment in the parent study, ALIVE.
‡
High-risk sex is defined as anonymous and/or traded sex, sex with multiple partners without always using condom, and/or sex with injection drug user(s) without always using condom.
HIV indicates human immunodeficiency virus; HAART, highly active antiretroviral therapy; N/A, not applicable.